Informationen:
Fehler:
ID
28972
Beschreibung
Study part: Follow- up Contact Month 3. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Stichworte
Versionen (1)
- 18.02.18 18.02.18 -
Rechteinhaber
Roche
Hochgeladen am
18. Februar 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Follow- up Contact Month 3 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Follow- up Contact Month 3
- StudyEvent: ODM
Ähnliche Modelle
Follow- up Contact Month 3
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
text
C1320303 (UMLS CUI [1])
follow-up visit
Item
Was the subject contacted 2 days after study treatment?
boolean
C0589121 (UMLS CUI [1])
Date of Contact
Item
Date of Contact:
date
C0805839 (UMLS CUI [1])
post treatment antibodies
Item
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
boolean
C2709088 (UMLS CUI [1,1])
C0003241 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,2])
Low Vision
Item
Decrease in Vision- Has the subject experienced a decrease in vision in the study eye since treatment?
boolean
C0042798 (UMLS CUI [1])
Eye Pain
Item
Eye Pain- Has the subject had any eye pain in the study eye since treatment?
boolean
C0151827 (UMLS CUI [1])
eye redness
Item
Unusual Redness- Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
boolean
C0235267 (UMLS CUI [1])
Ocular Symptoms
Item
New Ocular Symptoms- Has the subject experienced any other new ocular symptoms in the study eye since treatment?
boolean
C0586406 (UMLS CUI [1])
Safety Assessment Visit
Item
Safety Assessment Visit- Was the subject asked to return to the clinic for a safety assessment visit?
boolean
C0589121 (UMLS CUI [1,1])
C0549076 (UMLS CUI [1,2])
C0549076 (UMLS CUI [1,2])